Susquehanna International Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$259K Buy
+2,500
New +$264K ﹤0.01% 11182
2021
Q3
Sell
-10,800
Closed -$869K 13360
2021
Q2
$869K Sell
10,800
-34,500
-76% -$2.74M ﹤0.01% 8159
2021
Q1
$3.57M Buy
+45,300
New +$3.53M ﹤0.01% 4587
2017
Q3
Sell
-7,300
Closed -$458K 9434
2017
Q2
$458K Sell
7,300
-1,100
-13% -$66K ﹤0.01% 6814
2017
Q1
$494K Buy
8,400
+3,000
+56% +$175K ﹤0.01% 6503
2016
Q4
$303K Buy
+5,400
New +$311K ﹤0.01% 7951
2016
Q3
Sell
-5,500
Closed -$348K 8885
2016
Q2
$348K Sell
5,500
-16,100
-75% -$1.01M ﹤0.01% 6721
2016
Q1
$1.3M Buy
21,600
+13,100
+154% +$801K ﹤0.01% 4566
2015
Q4
$595K Sell
8,500
-4,800
-36% -$340K ﹤0.01% 6436
2015
Q3
$882K Sell
13,300
-5,600
-30% -$436K ﹤0.01% 6032
2015
Q2
$1.48M Buy
18,900
+6,200
+49% +$483K ﹤0.01% 5360
2015
Q1
$970K Buy
12,700
+1,600
+14% +$118K ﹤0.01% 5832
2014
Q4
$738K Buy
+11,100
New +$739K ﹤0.01% 6458
2014
Q3
Sell
-3,300
Closed -$202K 9815
2014
Q2
$202K Buy
+3,300
New +$191K ﹤0.01% 9050

Other funds holding PJP

Susquehanna International Group's PJP Position: Q3 2025 in Review

Susquehanna International Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2025, closing a stake of 6,825 shares — an estimated $545K sold.

Susquehanna International Group first reported a position in PJP in Q2 2013 and held it in 43 quarters. The position peaked at $4.8M in Q1 2016. 93 funds tracked by Wall St. Rank hold PJP as of Q3 2025.

  • Susquehanna International Group reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 6,825 Invesco Pharmaceuticals ETF shares in Q3 2025, an estimated $545K.
  • Susquehanna International Group first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 43 quarters.
  • Susquehanna International Group's Invesco Pharmaceuticals ETF position peaked at $4.8M in Q1 2016.
  • 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.